Results 81 to 90 of about 13,942 (231)

Distribution of OCA2*481Thr and OCA2*615Arg, associated with hypopigmentation, in several additional populations

open access: yes, 2011
Two mutants, OCA2*481Thr (c.1441G > A, p.Ala481Thr) and OCA2*615Arg (c.1844A > G, p.His615Arg), in the OCA2 (oculocutaneous albinism type II) gene are associated with hypopigmentation in East Asians.
Yuasa, Isao   +9 more
core  

Afecciones dermatológicas con hipopigmentación en un área de salud. Mayo-diciembre, 2010</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Revista Médica Electrónica</i>, 2011 </span><br><span class="r_content">Las afecciones cutáneas con hipopigmentación constituyen una causa frecuente de consulta en el mundo y en, ya que es un síntoma común a numerosas enfermedades dermatológicas, pero hasta el momento, a pesar de la revisión bibliográfica realizada, se ha ...</span><br><span class="r_sub"><i>Tamara M Pérez Martell<span id="ma_2" style="display:none">, Isahiris González García</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_2')">+1 more</a></small></i></span><br><small><a href="https://doaj.org/article/7cfd28254f3a455da8ca264857755269" target="_blank" rel="nofollow" title="doaj.org/article/7cfd28254f3a455da8ca264857755269">doaj</a> </small>   <br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.1111/pde.70294" target="_blank" rel="nofollow">Cutis Tricolor‐Like Pigmentary Mosaicism in Mowat–Wilson Syndrome: Phenotypic Overlap With Ruggieri–Happle Syndrome</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Pediatric Dermatology, EarlyView.</i></span><br><span class="r_content">ABSTRACT Cutis tricolor (CT) is a rare pigmentary mosaicism characterized by the coexistence of hyperpigmented and hypopigmented areas on a background of normal skin; its syndromic form, Ruggieri–Happle syndrome (RHS), is associated with neurodevelopmental delay, facial dysmorphism, skeletal abnormalities, and other systemic defects.</span><br><span class="r_sub"><i>Didier Bessis<span id="ma_3" style="display:none">, Pierre Meyer, Marjolaine Willems</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_3')">+2 more</a></small></i></span><br><small><a href="https://onlinelibrary.wiley.com/doi/10.1111/pde.70294?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default" target="_blank" rel="nofollow" title="wiley.com/doi/10.1111/pde.70294?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default">wiley</a> </small>   <div id="more_3" style="display:none"><a href="/sci_redir.php?doi=10.1111%2Fpde.70294" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.1111/pde.70294'); alert('Copied the doi');">copy doi</a> <small>(10.1111/pde.70294)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_3')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.4103/0972-1363.57777" target="_blank" rel="nofollow">Discoid lupus erythematosus: A case report with review of the literature</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Journal of Indian Academy of Oral Medicine and Radiology</i>, 2009 </span><br><span class="r_content">Discoid lupus erythematosus (DLE) is the most common form of chronic cutaneous lupus erythematosus. Classic DLE lesions begin as red-purple macules, papules or small plaques and rapidly develop a hyperkeratotic surface.</span><br><span class="r_sub"><i>C K Sreejan<span id="ma_4" style="display:none">, R Gopakumar, Subhas Babu, R K Roopashri</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_4')">+3 more</a></small></i></span><br><small><a href="https://doaj.org/article/92e9c769fcb748c191d442dba3cba809" target="_blank" rel="nofollow" title="doaj.org/article/92e9c769fcb748c191d442dba3cba809">doaj</a> </small>   <div id="more_4" style="display:none"><a href="/sci_redir.php?doi=10.4103%2F0972-1363.57777" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.4103/0972-1363.57777'); alert('Copied the doi');">copy doi</a> <small>(10.4103/0972-1363.57777)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_4')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.1111/cup.70068" target="_blank" rel="nofollow">PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"></span><br><span class="r_content">Journal of Cutaneous Pathology, EarlyView.</span><br><span class="r_sub"><i>Annie Jin<span id="ma_5" style="display:none">, Katherine T. Steele, Emily Y. Chu</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_5')">+2 more</a></small></i></span><br><small><a href="https://onlinelibrary.wiley.com/doi/10.1111/cup.70068?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default" target="_blank" rel="nofollow" title="wiley.com/doi/10.1111/cup.70068?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default">wiley</a> </small>   <div id="more_5" style="display:none"><a href="/sci_redir.php?doi=10.1111%2Fcup.70068" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.1111/cup.70068'); alert('Copied the doi');">copy doi</a> <small>(10.1111/cup.70068)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_5')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.1111/vde.70062" target="_blank" rel="nofollow">Dermatological Adverse Events Associated With Lapatinib Treatment in Dogs With Urothelial Carcinoma: A Retrospective Study</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Veterinary Dermatology, EarlyView.</i></span><br><span class="r_content">Lapatinib is widely used in human oncology; however, dermatological adverse events (DAEs) are common and have been correlated with treatment efficacy. In veterinary medicine, lapatinib use in combination with piroxicam has been shown to be effective in treating canine urothelial carcinoma (UC); however, the incidence and prognostic significance of DAEs </span><br><span class="r_sub"><i>Kosuke Horita<span id="ma_6" style="display:none">, Tomohiro Yonezawa, Yasuyuki Momoi, Shingo Maeda</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_6')">+3 more</a></small></i></span><br><small><a href="https://onlinelibrary.wiley.com/doi/10.1111/vde.70062?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default" target="_blank" rel="nofollow" title="wiley.com/doi/10.1111/vde.70062?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default">wiley</a> </small>   <div id="more_6" style="display:none"><a href="/sci_redir.php?doi=10.1111%2Fvde.70062" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.1111/vde.70062'); alert('Copied the doi');">copy doi</a> <small>(10.1111/vde.70062)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_6')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.1016/s1658-3876(09)50026-x" target="_blank" rel="nofollow">Hypopigmentation of the skin due to imatinib mesylate in patients with chronic myeloid leukemia </a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16">, 2009 </span><br><span class="r_content">BACKGROUNDHypopigmentation is an infrequently reported adverse effect of imatinib mesylate (IM) in chronic myeloid leukemia (CML), but there are no reports from Arab or Saudi patients.</span><br><span class="r_sub"><i>Aleem, Aamer, Aamer Aleem</i></span><br><small><a href="https://core.ac.uk/works/41436174" target="_blank" rel="nofollow" title="core.ac.uk/works/41436174">core</a> </small>   <div id="more_7" style="display:none"><a href="/sci_redir.php?doi=10.1016%2Fs1658-3876%2809%2950026-x" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.1016/s1658-3876(09)50026-x'); alert('Copied the doi');">copy doi</a> <small>(10.1016/s1658-3876(09)50026-x)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_7')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.17632/rf2s8h2xgy.2" target="_blank" rel="nofollow">Association between the skin microbiome and lichen striatus hypopigmentation: Cutibacterium acnes as a potential cause - Supplementary materials</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16">, 2023 </span><br><span class="r_content">Supplementary materials for the research investigating the involvement of Cutibacterium acnes in the development of hypopigmentation in lichen striatusTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.</span><br><span class="r_sub"><i>Lee, B (via Mendeley Data)</i></span><br><small><a href="https://core.ac.uk/works/149061649" target="_blank" rel="nofollow" title="core.ac.uk/works/149061649">core</a> </small>   <div id="more_8" style="display:none"><a href="/sci_redir.php?doi=10.17632%2Frf2s8h2xgy.2" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.17632/rf2s8h2xgy.2'); alert('Copied the doi');">copy doi</a> <small>(10.17632/rf2s8h2xgy.2)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_8')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.1111/vde.70090" target="_blank" rel="nofollow">Efficacy of 0.5% Tretinoin in the Treatment of Equine Aural Plaques</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Veterinary Dermatology, EarlyView.</i></span><br><span class="r_content">Background: Equine aural plaques are a benign form of auricular papillomatosis caused by equine papillomavirus. Despite the efficacy of 5% imiquimod cream, a marked local reaction is frequently observed during therapy, often requiring sedation before application.</span><br><span class="r_sub"><i>Felipe Sperandio de Mattos<span id="ma_9" style="display:none">, Lissandro Gonçalves Conceição, Ytalo Galinari Henrique Schuartz, Vitória Régia Melo Silva, Cintia Fernandes Fidélis, Fernanda Campos Mansur, Cristian Silva Teixeira, Yame Fabres Robaina Sancler‐Silva, Jose Paes Oliveira‐Filho, Alexandre Secorun Borges, Cristiana Raach Bromberger, José Dantas Ribeiro Filho, Marcel Ferreira Bastos Avanza, José Ricardo Barboza Silva, Raffaella Bertoni Cavalcanti Teixeira</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_9')">+14 more</a></small></i></span><br><small><a href="https://onlinelibrary.wiley.com/doi/10.1111/vde.70090?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default" target="_blank" rel="nofollow" title="wiley.com/doi/10.1111/vde.70090?mi=2or9o2m&af=R&AllField=hypopigmentation&ConceptID=15941&content=articlesChapters&target=default">wiley</a> </small>   <div id="more_9" style="display:none"><a href="/sci_redir.php?doi=10.1111%2Fvde.70090" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.1111/vde.70090'); alert('Copied the doi');">copy doi</a> <small>(10.1111/vde.70090)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_9')">+1 more source</a></small><br></div><div class="r"><p class="r_title"><a href="https://doi.org/10.3389/fmed.2022.1016741" target="_blank" rel="nofollow">Editorial: Mechanisms and novel treatments of pigmentary disorders and skin regeneration</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Frontiers in Medicine</i>, 2022 </span><br><span class="r_sub"><i>Xing-Hua Gao</i></span><br><small><a href="https://doaj.org/article/1274a50b49264a8c8bfedf522b200c29" target="_blank" rel="nofollow" title="doaj.org/article/1274a50b49264a8c8bfedf522b200c29">doaj</a> </small>   <div id="more_10" style="display:none"><a href="/sci_redir.php?doi=10.3389%2Ffmed.2022.1016741" target="_blank" rel="nofollow">openaccessbutton.org (pdf)</a><br><a href="javascript:navigator.clipboard.writeText('10.3389/fmed.2022.1016741'); alert('Copied the doi');">copy doi</a> <small>(10.3389/fmed.2022.1016741)</small><br></div><small><a href="#" onClick="return toggle_div(this, 'more_10')">+1 more source</a></small><br></div><div class="r"><div style="margin-bottom:2px;overflow:hidden"><div style="display: inline-block; float: left; font-size: small; padding-right: 16px; margin-top: -1px; padding-bottom: 1px;"><a href="/q-humans/" class="suggestion"onclick="show_loader();"><b>humans</b></a><br/><a href="/q-3._good_health/" class="suggestion"onclick="show_loader();"><b>3. good health</b></a><br/><a href="/q-vitiligo/" class="suggestion"onclick="show_loader();"><b>vitiligo</b></a><br/></div><div style="display: inline-block; float: left; font-size: small; padding-right: 16px; margin-top: -1px; padding-bottom: 1px;"><a href="/q-female/" class="suggestion"onclick="show_loader();"><b>female</b></a><br/><a href="/q-pigmentation_disorders/" class="suggestion"onclick="show_loader();"><b>pigmentation disorders</b></a><br/><a href="/q-hyperpigmentation/" class="suggestion"onclick="show_loader();"><b>hyperpigmentation</b></a><br/></div><div style="display: inline-block; float: left; font-size: small; padding-right: 16px; margin-top: -1px; padding-bottom: 1px;"><a href="/q-melanocytes/" class="suggestion"onclick="show_loader();"><b>melanocytes</b></a><br/><a href="/q-male/" class="suggestion"onclick="show_loader();"><b>male</b></a><br/><a href="/q-diagnosis%2C_differential/" class="suggestion"onclick="show_loader();"><b>diagnosis, differential</b></a><br/></div></div></div><div class="pagenav"><a href="/q-hypopigmentation/p-8/" rel="nofollow"><b>previous</b></a>   <a href="/q-hypopigmentation/p-7/" rel="nofollow">7</a>  <a href="/q-hypopigmentation/p-8/" rel="nofollow">8</a>  <b>9</b>  <a href="/q-hypopigmentation/p-10/" rel="nofollow">10</a>  <a href="/q-hypopigmentation/p-11/" rel="nofollow">11</a>   <a href="/q-hypopigmentation/p-10/" id="next" rel="nofollow"><b>next</b></a> </div><br></div> </div> <script>document.getElementById('loadingGif').style.display='none';</script><div style="width: 100%; height: 40px; bottom: 0px; background-color: #f5f5f5;"><div style="padding-left: 15px; padding-top: 10px"> <a href="/" rel="nofollow">Home</a> - <a href="/page-about/" rel="nofollow">About</a> - <a href="/page-disclaimer/" rel="nofollow">Disclaimer</a> - <a href="/page-privacy/" rel="nofollow">Privacy</a> </div></div> <link rel="stylesheet" href="//ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/themes/smoothness/jquery-ui.min.css"/> <script> (function(ss,ex){ window.ldfdr=window.ldfdr||function(){(ldfdr._q=ldfdr._q||[]).push([].slice.call(arguments));}; (function(d,s){ fs=d.getElementsByTagName(s)[0]; function ce(src){ var cs=d.createElement(s); cs.src=src; cs.async=1; fs.parentNode.insertBefore(cs,fs); }; ce('https://sc.lfeeder.com/lftracker_v1_'+ss+(ex?'_'+ex:'')+'.js'); })(document,'script'); })('JMvZ8gvrWA9a2pOd'); </script> </body> </html>